Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

L Matthew Sherman

Affiliations

  • Evp & Chief Medical Officer at Deciphera Pharmaceuticals Inc. (DCPH), 2019-10-17
  • Director at Newlink Genetics Corp ((NLNK)), 2019-08-02
  • Director at Pulmatrix Inc. (PULM), 2019-05-20
  • at Pieris Pharmaceuticals Inc. (PIRS), 2019-01-29
  • Evp & Chief Medical Officer at Acceleron Pharma Inc (XLRN), 2018-04-04
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
PULM $0.00 20,000 Director 20,000 2018-04-03 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
XLRN $39.04 900 Officer 68,767 2018-04-03 Filing
XLRN $38.28 3,700 Officer 69,667 2018-04-03 Filing
XLRN $43.33 2,033 Officer 73,367 2018-01-03 Filing
XLRN $42.40 2,300 Officer 75,400 2018-01-03 Filing
XLRN $40.86 300 Officer 77,700 2018-01-03 Filing